<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Unregulated fibroblast growth factor 2 (FGF2) signaling caused by mutations in the fibroblast growth factor receptor (FGFR2) leads to human <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> such as the <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In an in vitro control model of calvarial osteoblasts from <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> patients carrying the FGFR2 P253R mutation, we studied the changes in <z:mp ids='MP_0005384'>cellular phenotype</z:mp> and evaluated the effects of FGF2 </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with <z:mp ids='MP_0002169'>wild-type</z:mp> controls, osteocalcin <z:chebi fb="2" ids="33699">mRNA</z:chebi> was down-regulated in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts, <z:mp ids='MP_0001265'>Runt</z:mp>-related transcription factor-2 (RUNX2) <z:chebi fb="2" ids="33699">mRNA</z:chebi> was differentially spliced, and FGF2 secretion was greater </plain></SENT>
<SENT sid="3" pm="."><plain>Total protein synthesis, fibronectin and type I collagen secretion were up-regulated, while protease and glycosidase activities and matrix metalloproteinase-13 (MMP-13) transcription were decreased, suggesting an altered ECM turnover </plain></SENT>
<SENT sid="4" pm="."><plain>Adding FGF2 increased protease and glycosidase activities and down-regulated fibronectin and type I collagen secretion in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts </plain></SENT>
<SENT sid="5" pm="."><plain>High affinity FGF2 receptors were up-regulated in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts and analysis of signal transduction showed elevated levels of Grb2 tyrosine phosphorylation and the Grb2-p85 beta association, which FGF2 stimulation strongly reduced </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> together these findings suggest increased constitutive receptor activity in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> mutant osteoblasts and an autocrine loop involving the FGF2 pathway in modulation of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblast behavior </plain></SENT>
</text></document>